AstraZeneca Says Vaccine Trial Analysis Shows 76 Percent Efficacy
The British-Swedish drugmaker made a new announcement based on a primary analysis of its recent study. What We Know: On Monday, the company announced results […]
AstraZeneca Says U.S. Trial Data Shows its Covid-19 Vaccine is 79 Percent Effective
The company announced Monday its vaccine effectively prevents severe illness and hospitalizations across all age groups and ethnicities. What We Know: The vaccine, developed in […]
‘New Pandemic’ in Germany Caused by Virus Variant Prompts Lockdown Through Easter
The country will extend its current lockdown as the nation grapples with increasing infections amid a third wave of the coronavirus. What We Know: German […]
Biden Administration to Share Millions of AstraZeneca Vaccine Doses With Canada, Mexico
The White House announced on Thursday that it’s finalizing plans to send doses of the vaccine to its northern and southern neighbors. What We Know: […]
South Africa Halts AstraZeneca Vaccine After Study Questions Effectiveness Against Variant
South Africa has suspended the use of the Oxford-AstraZeneca vaccine on front-line workers after a small trial suggested it isn’t effective against the country’s dominant […]
England Announces New Lockdown, Stricter Than March
The UK Prime Minister has ordered new lockdown measures due to COVID-19. These are said to be stricter than the ones in March. What We […]
Viral TikToks Offer Firsthand Accounts of Vaccine Trials, Debunk Misinformation
As we come closer to a coronavirus vaccine, TikTok users have come to share their experience with the vaccine trial. What We Know The AstraZeneca […]
AstraZeneca Says its Coronavirus Vaccine Triggers Immune Response Among Adults
The push to produce a vaccine for COVID-19 seems to have taken another leap recently. British pharmaceutical giant AstraZeneca stated on Monday that AZD1222, the […]
AstraZeneca Oxford COVID-19 Vaccine Trial on Hold
On Tuesday, pharmaceutical giant AstraZeneca announced it was temporarily pausing its global phase three trials of its possible coronavirus vaccine after one participant suffered an […]